» Articles » PMID: 32239535

Left Prefrontal Connectivity Links Subthalamic Stimulation with Depressive Symptoms

Overview
Journal Ann Neurol
Specialty Neurology
Date 2020 Apr 3
PMID 32239535
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson's disease (PD) not only stimulates focal target structures but also affects distributed brain networks. The impact this network modulation has on non-motor DBS effects is not well-characterized. By focusing on the affective domain, we systematically investigate the impact of electrode placement and associated structural connectivity on changes in depressive symptoms following STN-DBS, which have been reported to improve, worsen, or remain unchanged.

Methods: Depressive symptoms before and after STN-DBS surgery were documented in 116 patients with PD from 3 DBS centers (Berlin, Queensland, and Cologne). Based on individual electrode reconstructions, the volumes of tissue activated (VTAs) were estimated and combined with normative connectome data to identify structural connections passing through VTAs. Berlin and Queensland cohorts formed a training and cross-validation dataset used to identify structural connectivity explaining change in depressive symptoms. The Cologne data served as the test-set for which depressive symptom change was predicted.

Results: Structural connectivity was linked to depressive symptom change under STN-DBS. An optimal connectivity map trained on the Berlin cohort could predict changes in depressive symptoms in Queensland patients and vice versa. Furthermore, the joint training-set map predicted changes in depressive symptoms in the independent test-set. Worsening of depressive symptoms was associated with left prefrontal connectivity.

Interpretation: Fibers connecting the electrode with left prefrontal areas were associated with worsening of depressive symptoms. Our results suggest that for the left STN-DBS lead, placement impacting fibers to left prefrontal areas should be avoided to maximize improvement of depressive symptoms. ANN NEUROL 2020;87:962-975.

Citing Articles

Neurophysiological gradient in the Parkinsonian subthalamic nucleus as a marker for motor symptoms and apathy.

Bernasconi E, Amstutz D, Averna A, Fischer P, Sousa M, Debove I NPJ Parkinsons Dis. 2025; 11(1):4.

PMID: 39753562 PMC: 11698975. DOI: 10.1038/s41531-024-00848-2.


The effect of pallidal stimulation on sleep outcomes and related brain connectometries in Parkinson's disease.

Zheng Z, Liu D, Fan H, Xie H, Zhang Q, Qin G NPJ Parkinsons Dis. 2024; 10(1):212.

PMID: 39496609 PMC: 11535399. DOI: 10.1038/s41531-024-00800-4.


Evaluating a motor progression connectivity model across Parkinson's disease stages.

Hacker M, Isaacs D, Rajamani N, Pazira K, Abdou E, Sharp S J Neurol. 2024; 271(11):7309-7315.

PMID: 39373780 PMC: 11561123. DOI: 10.1007/s00415-024-12703-8.


Unveiling the Dominant Factors in Subthalamic Stimulation for Improving Depression in Parkinson's Disease.

Zhao G, Cheng Y, Li G, Li L, Li F, Wu Y Mov Disord Clin Pract. 2024; 11(12):1478-1488.

PMID: 39262097 PMC: 11647981. DOI: 10.1002/mdc3.14195.


Enhancing early Parkinson's disease detection through multimodal deep learning and explainable AI: insights from the PPMI database.

Dentamaro V, Impedovo D, Musti L, Pirlo G, Taurisano P Sci Rep. 2024; 14(1):20941.

PMID: 39251639 PMC: 11385236. DOI: 10.1038/s41598-024-70165-4.